GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (NSE:METROPOLIS) » Definitions » Change In Receivables

Metropolis Healthcare (NSE:METROPOLIS) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare Change In Receivables?

Metropolis Healthcare's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Metropolis Healthcare's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Metropolis Healthcare's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-119 Mil. It means Metropolis Healthcare's Accounts Receivable increased by ₹119 Mil from Mar. 2024 to Mar. 2025 .

Metropolis Healthcare's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹1,479 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Metropolis Healthcare's Days Sales Outstanding for the three months ended in Mar. 2025 was 39.10.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Metropolis Healthcare's liquidation value for the three months ended in Mar. 2025 was ₹-2,723 Mil.


Metropolis Healthcare Change In Receivables Historical Data

The historical data trend for Metropolis Healthcare's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare Change In Receivables Chart

Metropolis Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -138.95 116.85 158.27 -123.70 -118.89

Metropolis Healthcare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Metropolis Healthcare Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metropolis Healthcare  (NSE:METROPOLIS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Metropolis Healthcare's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1479.478/3452.915*91
=39.10

2. In Ben Graham's calculation of liquidation value, Metropolis Healthcare's accounts receivable are only considered to be worth 75% of book value:

Metropolis Healthcare's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1255.381-5327.009+0.75 * 1479.478+0.5 * 478.407
=-2,723

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metropolis Healthcare Change In Receivables Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Metropolis Healthcare Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines